The FDA's vaccine advisory committee unanimously recommended Moderna's new m-r-n-a influenza vaccine for adults fifty and older. All nine committee members voted in favor — marking the first new flu vaccine to receive such backing since twenty twenty-three. The shot uses the same m-r-n-a technology behind COVID vaccines, now applied to seasonal flu protection. According to NPR, the unanimous recommendation reflects strong scientific consensus on the vaccine's safety and effectiveness.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton